Long-term analysis of left ventricular ejection fraction in patients with stable multivessel coronary disease undergoingmedicine, angioplasty or surgery: 10-year follow-up of the MASS II trial

European Heart Journal

Volumn 34, Issue 43, 2013, Pages 3370-3377

  Garzillo, Cibele Larrosa ^a   Hueb, Whady ^a   Gersh, Bernard J ^b   Lima, Eduardo Gomes ^a   Rezende, Paulo Cury ^a   Hueb, Alexandre Ciappina ^a   Vieira, Ricardo D'Oliveira ^a   Favarato, Desiderio ^a   Pereira, Alexandre Costa ^a   Soares, Paulo Rogério ^a   Serrano Jr , Carlos Vicente ^a   Ramires, José Antônio Franchini ^a   Filho, Roberto Kalil ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b MAYO CLINIC   (United States)

Author keywords

Coronary artery disease; Coronary bypass surgery; Left ventricular ejection fraction; Medical therapy; Percutaneous coronary intervention

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIASTOLIC DYSFUNCTION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PHARMACEUTICAL CARE; POST HOC ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STABLE ANGINA PECTORIS; STABLE MULTIVESSEL CORONARY DISEASE; TRANSTHORACIC ECHOCARDIOGRAPHY; TREADMILL EXERCISE;

CORONARY ARTERY DISEASE; CORONARY BYPASS SURGERY; LEFT VENTRICULAR EJECTION FRACTION; MEDICAL THERAPY; PERCUTANEOUS CORONARY INTERVENTION;

AGED; ANALYSIS OF VARIANCE; CARDIOVASCULAR AGENTS; CORONARY ARTERY BYPASS; CORONARY STENOSIS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PERCUTANEOUS CORONARY INTERVENTION; STROKE; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84890531862     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht201     Document Type: Article

References (31)

1. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation 2003;107:346-354.
2. LakattaEG.Changes incardiovascular functionwith aging. EurHeart J1990;11 (SupplC): 22-29.
3. Pugh KG, Wei JY. Clinical implications of physiological changes in the aging heart. Drugs Aging 2001;18:263-276.
4. Cheng S, Fernandes VR, Bluemke DA, McClelland RL, Kronmal RA, Lima JA. Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging 2009;2: 191-198.
5. Stefanidis A, Bousboulas S, Kalafatis J, Baroutsi K, Margos P, Komninos K, Pappas S, Papasteriadis E. Left ventricular anatomical and functional changes with aging in type 2 diabetic adults. Eur J Echocardiogr 2009;10:647-653.
6. Hammermeister KE, DeRouen TA, Dodge HE. Variables predictive of survival in patients with coronary artery disease: selection by univariate and multivariate analysis from the clinical, electrocardiographic exercise, arteriographic and quantitative angiographic evaluation. Circulation 1979;59:421-430.
7. Weiner DA, RyanT,McCabe CH,Chaitman BR, Sheffield LT, Ferguson JC, Fisher LD, Tristani F. Prognostic importance of clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol 1984;3:772-779.
8. Mock MB, Ringgvist I, Fisher LD, Davis KB, Chaitman BR, Kouchoukos NT, Kaiser GC, Alderman E, Ryan TJ, Russell RO, Mullin S, Fray D, Killip T 3rd. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation 1982;66:562-568.
9. Daly CA, De Stavola B, Sendon JL, Tavazzi L, Boersma E, Clemens F, Danchin N, Delahaye F, Gitt A, Julian D, Mulcahy D, Ruzyllo W, Thygesen K, Verheugt F, Fox KM; Euro Heart Survey Investigators. Predicting prognosis in stable angina -results from the Euro heart survey of stable angina: prospective observational study. BMJ 2006;332:262-267.
10. Detre K, Peduzzi P, Murphy M, Hultgren H, Thomsen J, Oberman A, Takaro T. Effect of bypass surgery on survival in patients with low-And high risk subgroups delineated by use of simple clinical variables. Circulation 1981;63:1329-1338.
11. Shaw LJ,Weintraub WS, Maron DJ, Hartigan PM, Hachamovitch R, Min JK, Dada M, Mancini GB, Hayes SW, O'Rourke RA, Spertus JA, Kostuk W, Gosselin G, Chaitman BR, Knudtson M, Friedman J, Slomka P, Germano G, Bates ER, Teo KK, Boden WE, Berman DS. Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. Am Heart J 2012;164:243-250.
12. Hochman J, Maron D for the ISCHEMIA trial Investigators. International study of comparative health effectiveness with medical and invasive approaches. Study in progress. http://www.ischemiatrial.org.
13. Gibbson RJ, Miller DD, Liu P, Guo P, Brooks MM, Schwaiger M. Similarity of ventricular function in patients alive 5 years after randomization to surgery or angioplasty in the BARI trial. Circulation 2001;103:1076-1082.
14. Buszman P, Wiernek S, Szymanski R, Bialkowska B, Buszman P, Fil W, Stables R, Bochenek A, Martin J, Tendera M. Percutaneous versus surgical revascularization for multivessel coronary artery disease: A single center 10 year follow-up of SOS trial patients. Catheter Cardiovasc Interv 2009;74:420-426.
15. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients withmultivessel disease. N Engl J Med 1996;335:217-225.
16. SoS Investigators. Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): A randomised controlled trial. Lancet 2002; 360:965-970.
17. Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, Rodriguez-Granillo G, HuebWA, Lemos PA, Serruys PW. Long-Term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: A meta-Analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 2008;118:1146-1154.
18. BARI 2D Study Group, Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, Orchard TJ, Chaitman BR, Genuth SM, Goldberg SH, Hlatky MA, Jones TL, Molitch ME, NestoRW, Sako EY, Sobel BE. Arandomized trial of therapies for type 2 diabetes and coronary artery disease. NEngl J Med 2009;360:2503-2515.
19. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, Spertus JA, Berman DS, Mancini GB, Weintraub WS; COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356: 1503-1516.
20. HuebW, Soares PR, Gersh BJ, Cesar LAM, Luz PL, Puig LB, Martinez EM, Oliveira SA, Ramires JAF. The Medicine, Angioplasty, or Surgery Study (MASS-II): A randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease. J Am Coll Cardiol 2004;43:1743-1751.
21. Hueb W, Lopes N, Gersh BJ, Soares PR, Ribeiro EE, Pereira AC, Favarato D, Rocha AS, Hueb AC, Ramires JA. Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): A randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 2010; 122:949-957.
22. Douglas JR Jr, King SB III, Roubin GS. Technique of percutaneous transluminal angioplasty of coronary, renal, mesenteric, and peripheral arteries. In: Hurst JW, Schlant RC, Rackely CE, eds. The Heart. 7th ed. New York, NY: McGraw-Hill; 1990:2131-2153.
23. Jones EL, Craver JM, King SB III, Douglas JS, Bradford JM, Brown CM, Bone DK, Hatcher CR Jr. Clinical, anatomic and functional descriptors influencing morbidity, survival and adequacy of revascularization following coronary bypass. Ann Surg 1980;192:390-402.
24. Campeau L. Grading of angina pectoris. Circulation 1976;54:522-523.
25. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-367.
26. Rosner B. Fundamentals of Biostatistics. 2nd ed. Boston: PWS Publishers, 1986.
27. Timm NH. Multivariate Analysis with Applications in Educations and Psychology. Monterrey, CA: Brooks/Cole, 1975.
28. Panza JA. Coronary atherosclerosis: extending to the microcirculation Eur Heart J 2010;31:905-907.
29. Rubinshtein R, Yang EH, Rihal CS, Prasad A, Lennon RJ, Best PJ, Lerman LO, Lerman A. Coronary microcirculatory vasodilator function in relation to risk factors among patients without obstructive coronary disease and low to intermediate Framingham score. Eur Heart J 2010;31:936-942.
30. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007;356: 830-840.
31. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, Weintraub WS, O'Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, Boden WE; COURAGE Investigators. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-1291.